$13B… $17B… $20B… How Big Will They Get?

I am very excited.

As I announced last Friday, I’m very close to revealing my latest VPO recommendation.

I will have my research report on it finished within the next two weeks.

You’ll want to get your hands on it ASAP. Because the company I’ve been researching and crunching the numbers on is smack dab in the middle of the hottest investing opportunity on the planet.

In last week’s video, I mentioned why I’m so excited about the healthcare sector.

It’s the biggest individual slice of the nation’s economy. It employs more folks than any other sector. And, here’s the big thing, solving just one small problem in a sector this large can spell huge profit opportunities.

And solving a big problem… oh boy, that’s where the riches lie.

$20 Billion Richer

You know I’m a big fan of artificial intelligence. It’s not the scary stuff of sci-fi movies.

No… it’s solving real-world problems – especially in the data-rich world of healthcare.

It’s also showing the riches that come when a small startup gets sniffed out by the deep-pocketed folks in Big Tech.

Nuance Communications is a healthcare company that makes doctors’ jobs just a bit easier. It streamlines paperwork and makes record-keeping simpler.

That should be good for a few bucks, right?

Microsoft recently paid $20 billion for the company – its second-largest acquisition ever. Its only bigger deal was its $26 billion acquisition of LinkedIn.

Early investors in Nuance made out like bandits.

Of course, they weren’t alone. This type of big-money acquisition is all too common in the realm of healthcare startups.

Baxter International recently acquired medical tech provider Hillrom for $10.5 billion.

UnitedHealth Group’s Optum unit bought data analytics company Change Healthcare for $13 billion.

And two major venture capital firms bought healthcare IT company Athenahealth for $17 billion.

But it doesn’t stop there.

Even Bigger Deals Coming

Take the startup unicorn Lyra Health, for example. It hasn’t been bought out yet… but it’s getting huge amounts of money thrown at it.

In a Series G funding round in January, it received a $235 million investment, giving the company a valuation of $5.6 billion.

This showed the huge value of having a proven leader at the helm.

Lyra’s founder was formerly the chief financial officer at Facebook and Genentech. He knows a thing or two about startup finances.

Another startup called Ro just became a unicorn… five times over.

Its Series D round brought in half a billion bucks, putting the company’s valuation at $5 billion.

The company is the only one in the sector to combine nationwide telemedicine, pharmacy distribution and in-home care. It started less than four years ago selling erectile dysfunction medication and hair loss supplements.

It shows the value of getting into a stock that taps a broad market.

Insiders now say it’s not a question of if the company goes public… but when.

After all, one if its biggest competitors – Hims & Hers Health (HIMS) – went public in January through a SPAC (special purpose acquisition company) deal.

It was valued at $1.6 billion.

Hims, too, started in just 2017. It became a billion-dollar unicorn in less than two years.

The money that’s floating around in the American healthcare sector right now is flat-out off the charts.

It’s insane. And it’s not letting up.

As the U.S. population ages… as we all spend more and more each year on our health… and as new technology changes the marketplace… big money will flow to the best companies.

Healthcare is the HOT sector to get into now.

And I’m just about ready to pull the trigger on what I think is the hottest of the hot companies in it.

As a Venture Spotlight subscriber, you’ll be among the first to be notified when my research is available.

Keep an eye on your inbox.

Just a few bucks in this one could change lives… like yours.